glp 1 agonist review article GLP-1 Receptor Agonists: Effects on Glucose, Weight, and Cardiovascular Outcomes | Scott Isaacs, MD, FACP, FACE posted on the topic Top GLP-1 Agonists Balance Weight
Description
The relationship is always the same
Semaglutide in Adults with Type 1 Diabetes and Obesity
Due to these significant and reproducible results and because of the economic impact of the North American weight loss industry ($USD145.57 billion per year [$CAD197.9 billion]), semaglutide received nine million prescriptions in the United States within the last quarter of 2022, resulting in medication shortages expected to last well into 2024
Some investigators have characterized Alzheimer's disease as "type 3 diabetes" due to observed insulin resistance in the brain, though this terminology remains controversial and is not universally accepted
Forty percentage of the individuals on the two highest doses of survodutide had a mean weight loss of 20%
